+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Diagnostic Substances Market by Product Type (Instruments, Kits & Assays, Reagents), End-User (Diagnostic Laboratories, Forensic Laboratories, Hospitals & Clinics), Application - Global Forecast 2025-2030- Product Image
Diagnostic Substances Market by Product Type (Instruments, Kits & Assays, Reagents), End-User (Diagnostic Laboratories, Forensic Laboratories, Hospitals & Clinics), Application - Global Forecast 2025-2030- Product Image
Sale

Diagnostic Substances Market by Product Type (Instruments, Kits & Assays, Reagents), End-User (Diagnostic Laboratories, Forensic Laboratories, Hospitals & Clinics), Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015434
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The diagnostic substances market is a foundational segment of global healthcare, supporting effective disease detection and monitoring through a wide array of instruments, kits, assays, and reagents. Senior decision-makers focused on innovation and operational efficiency will find the evolving landscape of this industry integral to shaping long-term strategies.

Market Snapshot: Diagnostic Substances Market Growth and Outlook

The Diagnostic Substances Market grew from USD 178.36 billion in 2024 to USD 189.53 billion in 2025. It is expected to continue growing at a CAGR of 6.48%, reaching USD 259.99 billion by 2030. This growth is driven by technological advancements, regulatory developments, and widespread adoption of innovative testing solutions across healthcare, research, and forensic sectors. Market participants are responding dynamically to shifting healthcare requirements and the expanding complexity of diagnostic demands.

Scope & Segmentation

This comprehensive research covers critical segments and emerging trends influencing strategic decisions in the diagnostic substances market:

  • Product Types: Analyzers, imaging equipment, molecular diagnostic instruments such as next-generation sequencing systems and PCR machines, ELISA kits, lateral flow assays, PCR kits, rapid test kits, and key reagents including antibody, antigen, enzyme, nucleic acid, and recombinant protein reagents.
  • End-Users: Diagnostic laboratories, forensic laboratories, hospitals and clinics, point-of-care testing facilities, and research or academic institutes.
  • Applications: Clinical diagnostics spanning cardiology, endocrinology, infectious disease, neurology, and oncology; forensic applications such as blood sample analysis, DNA testing, and toxicology; research applications in drug discovery, genomics, and proteomics.
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina, including key U.S. states), Europe Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, Saudi Arabia, South Africa), and Asia-Pacific (China, India, Japan, Australia, South Korea, and Southeast Asian nations).
  • Technologies: High-throughput sequencing, digital pathology, point-of-care platforms, microfluidics-based assays, and advanced data analytics platforms utilizing cloud and artificial intelligence.
  • Key Industry Players: Major companies including Abbott Laboratories, Agilent Technologies Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Illumina Inc., Roche AG, Thermo Fisher Scientific, and others.

Key Takeaways: Strategic Insights for Senior Stakeholders

  • Strategic realignment of portfolios, distribution, and partnerships is accelerating as organizations focus more sharply on precision medicine and digital health integrations.
  • High-throughput, decentralized, and near-patient testing models are changing operational paradigms and streamlining time-to-decision for healthcare providers.
  • Integration of cloud-based analytics and artificial intelligence is fostering expanded access to data-driven clinical and research insights, supporting broader test reach and optimized workflows.
  • Regulatory streamlining for companion diagnostics and point-of-care approvals has made market entry more manageable but increased the need for robust compliance strategies.
  • Growing adoption of reagent-as-a-service and equipment leasing models help reduce customer capital expenditure, promoting stable, recurring revenues for suppliers.
  • Sustainability considerations in reagent production and packaging are gaining traction amid environmental, social, and governance requirements.

Tariff Impact: United States Trade Policy and Supply Chain Adaptation

Recent United States tariffs have introduced supply chain and procurement challenges by increasing costs for instruments and reagents. Organizations are now ramping up localization and diversification of suppliers, as well as renegotiating distributor and customer contracts. These actions are intended to alleviate future trade-policy risks and support continuity in diagnostic service delivery.

Methodology & Data Sources

This diagnostic substances market analysis is built on primary interviews with executives across manufacturing, clinical laboratories, and regulatory agencies, supplemented by secondary sources including peer-reviewed literature, patent filings, and industry disclosures. Triangulated data and adherence to research ethics ensure robust, objective insights for leadership teams.

Why This Report Matters

  • Enables senior leaders to anticipate technology trends and evolving regulatory frameworks, supporting informed allocation of resources and risk management.
  • Supports portfolio optimization and strategic positioning by delivering actionable insights into segmentation, technology adoption, and regional dynamics.

Conclusion

The diagnostic substances market is advancing in complexity and strategic significance. Stakeholders that engage proactively with emerging trends and respond with adaptable business models will be suited to unlock continued value and growth in this dynamic landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Surge in regulatory approvals for CRISPR-based diagnostic reagents in infectious disease testing
5.2. Expansion of point-of-care molecular diagnostic platforms for antibiotic resistance detection
5.3. Integration of AI-powered image analysis in immunohistochemistry diagnostics to improve cancer subtype classification
5.4. Growing collaboration between diagnostic reagent suppliers and telemedicine platforms for remote sample analysis
5.5. Adoption of next-generation sequencing assays in liquid biopsy diagnostics for early cancer detection
5.6. Development of biodegradable microfluidic chips for eco friendly point-of-care diagnostic testing
5.7. Increased utilization of multiplexed immunoassays targeting cytokine profiles in autoimmune disease monitoring
5.8. Emergence of nanobody-based reagents enhancing sensitivity of in vitro diagnostic immunoassays
5.9. Surging demand for companion diagnostics aligned with targeted oncology therapies in precision medicine
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Diagnostic Substances Market, by Product Type
8.1. Introduction
8.2. Instruments
8.2.1. Analyzers
8.2.2. Imaging Equipment
8.2.3. Molecular Diagnostic Instruments
8.2.3.1. Next-Generation Sequencing
8.2.3.2. PCR Machines
8.3. Kits & Assays
8.3.1. ELISA Kits
8.3.2. Lateral Flow Assays
8.3.3. PCR Kits
8.3.4. Rapid Test Kits
8.4. Reagents
8.4.1. Antibody Reagents
8.4.2. Antigen Reagents
8.4.3. Enzymes
8.4.4. Nucleic Acid Reagents
8.4.5. Recombinant Proteins
9. Diagnostic Substances Market, by End-User
9.1. Introduction
9.2. Diagnostic Laboratories
9.3. Forensic Laboratories
9.4. Hospitals & Clinics
9.5. Point-of-Care Testing Facilities
9.6. Research & Academic Institutes
10. Diagnostic Substances Market, by Application
10.1. Introduction
10.2. Clinical Diagnostics
10.2.1. Cardiology
10.2.2. Endocrinology
10.2.3. Infectious Diseases
10.2.4. Neurology
10.2.5. Oncology
10.3. Forensic
10.3.1. Blood Sample Testing
10.3.2. DNA Analysis
10.3.3. Toxicology
10.4. Research
10.4.1. Drug Discovery
10.4.2. Genomics Research
10.4.3. Proteomics Research
11. Americas Diagnostic Substances Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Diagnostic Substances Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Diagnostic Substances Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Abbott Laboratories
14.3.2. Agilent Technologies Inc.
14.3.3. Asuragen, Inc. by Bio-Techne Corporation
14.3.4. Becton, Dickinson and Company
14.3.5. Bio-Rad Laboratories Inc.
14.3.6. bioLytical Laboratories
14.3.7. bioMérieux SA
14.3.8. Cepheid by Danaher Corporation
14.3.9. DiaSorin S.p.A.
14.3.10. Enzo Biochem, Inc.
14.3.11. Hitachi Ltd.
14.3.12. Hoffmann-La Roche AG
14.3.13. Hologic Inc.
14.3.14. HyTest Ltd.
14.3.15. Illumina Inc.
14.3.16. Merck KGaA
14.3.17. OraSure Technologies, Inc.
14.3.18. Ortho Clinical Diagnostics
14.3.19. Qiagen N.V.
14.3.20. Quidel Corporation
14.3.21. Randox Laboratories Ltd.
14.3.22. Sekisui Diagnostics, LLC
14.3.23. Siemens AG
14.3.24. Sysmex Corporation by TOA Corporation
14.3.25. Thermo Fisher Scientific Inc.
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. DIAGNOSTIC SUBSTANCES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. DIAGNOSTIC SUBSTANCES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. DIAGNOSTIC SUBSTANCES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. DIAGNOSTIC SUBSTANCES MARKET: RESEARCHAI
FIGURE 22. DIAGNOSTIC SUBSTANCES MARKET: RESEARCHSTATISTICS
FIGURE 23. DIAGNOSTIC SUBSTANCES MARKET: RESEARCHCONTACTS
FIGURE 24. DIAGNOSTIC SUBSTANCES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DIAGNOSTIC SUBSTANCES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY IMAGING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY IMAGING EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PCR MACHINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PCR MACHINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ELISA KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ELISA KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PCR KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PCR KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RAPID TEST KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RAPID TEST KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ANTIBODY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ANTIBODY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ANTIGEN REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ANTIGEN REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ENZYMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY NUCLEIC ACID REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY NUCLEIC ACID REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY POINT-OF-CARE TESTING FACILITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY POINT-OF-CARE TESTING FACILITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY BLOOD SAMPLE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY BLOOD SAMPLE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY DNA ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY DNA ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY TOXICOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY TOXICOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY GENOMICS RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY GENOMICS RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PROTEOMICS RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PROTEOMICS RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES DIAGNOSTIC SUBSTANCES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 145. CANADA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 146. CANADA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 147. CANADA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 148. CANADA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 149. CANADA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 150. CANADA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 151. CANADA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2024 (USD MILLION)
TABLE 152. CANADA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2025-2030 (USD MILLION)
TABLE 153. CANADA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 154. CANADA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 155. CANADA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 156. CANADA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 157. CANADA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. CANADA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. CANADA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 160. CANADA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 161. CANADA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2024 (USD MILLION)
TABLE 162. CANADA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2025-2030 (USD MILLION)
TABLE 163. CANADA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 164. CANADA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 165. MEXICO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. MEXICO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. MEXICO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 168. MEXICO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 169. MEXICO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 170. MEXICO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 171. MEXICO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2024 (USD MILLION)
TABLE 172. MEXICO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2025-2030 (USD MILLION)
TABLE 173. MEXICO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 174. MEXICO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 175. MEXICO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 176. MEXICO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 177. MEXICO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. MEXICO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. MEXICO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 180. MEXICO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 181. MEXICO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2024 (USD MILLION)
TABLE 182. MEXICO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2025-2030 (USD MILLION)
TABLE 183. MEXICO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 184. MEXICO DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 267. GERMANY DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 268. GERMANY DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 269. GERMANY DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 270. GERMANY DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 271. GERMANY DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 272. GERMANY DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 273. GERMANY DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2024 (USD MILLION)
TABLE 274. GERMANY DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2025-2030 (USD MILLION)
TABLE 275. GERMANY DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 276. GERMANY DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 277. GERMANY DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 278. GERMANY DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 279. GERMANY DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. GERMANY DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. GERMANY DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 282. GERMANY DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 283. GERMANY DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2024 (USD MILLION)
TABLE 284. GERMANY DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2025-2030 (USD MILLION)
TABLE 285. GERMANY DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 286. GERMANY DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 287. FRANCE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 288. FRANCE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 289. FRANCE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 290. FRANCE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 291. FRANCE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 292. FRANCE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 293. FRANCE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2024 (USD MILLION)
TABLE 294. FRANCE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2025-2030 (USD MILLION)
TABLE 295. FRANCE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 296. FRANCE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 297. FRANCE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 298. FRANCE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 299. FRANCE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. FRANCE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. FRANCE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 302. FRANCE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 303. FRANCE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2024 (USD MILLION)
TABLE 304. FRANCE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2025-2030 (USD MILLION)
TABLE 305. FRANCE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 306. FRANCE DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY KITS & ASSAYS, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 319. RUSSIA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 320. RUSSIA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 321. RUSSIA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 322. RUSSIA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 323. RUSSIA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2018-2024 (USD MILLION)
TABLE 324. RUSSIA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY FORENSIC, 2025-2030 (USD MILLION)
TABLE 325. RUSSIA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 326. RUSSIA DIAGNOSTIC SUBSTANCES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 327. ITALY DIAGNOSTIC SUBSTANCES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 328. ITALY DIAGNOSTIC SUBST

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Diagnostic Substances market report include:
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Asuragen, Inc. by Bio-Techne Corporation
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • bioLytical Laboratories
  • bioMérieux SA
  • Cepheid by Danaher Corporation
  • DiaSorin S.p.A.
  • Enzo Biochem, Inc.
  • Hitachi Ltd.
  • Hoffmann-La Roche AG
  • Hologic Inc.
  • HyTest Ltd.
  • Illumina Inc.
  • Merck KGaA
  • OraSure Technologies, Inc.
  • Ortho Clinical Diagnostics
  • Qiagen N.V.
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • Sekisui Diagnostics, LLC
  • Siemens AG
  • Sysmex Corporation by TOA Corporation
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 189.53 Billion
Forecasted Market Value ( USD ) by 2030 $ 259.99 Billion
Compound Annual Growth Rate6.4%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Oral Fluid Testing Market by Application, End User, Technology, Test Panel Size, Drug Class, Collection Device - Global Forecast 2025-2030 - Product Image

Oral Fluid Testing Market by Application, End User, Technology, Test Panel Size, Drug Class, Collection Device - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Clinical Diagnostics Market Size, Share, Trends and Forecast by Test, Product, End User, and Region, 2025-2033 - Product Image

Clinical Diagnostics Market Size, Share, Trends and Forecast by Test, Product, End User, and Region, 2025-2033

  • Report
  • 141 Pages
  • Global
From
Immunochemistry Diagnostic Devices and Equipment Market Report 2025 - Product Image

Immunochemistry Diagnostic Devices and Equipment Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Allergy Diagnostics - Global Strategic Business Report - Product Image

Allergy Diagnostics - Global Strategic Business Report

  • Report
  • 638 Pages
  • Global
From
Companion Diagnostics Market Report 2025 - Product Image

Companion Diagnostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Diagnostic Reagent Market

The Diagnostic Reagent market is a segment of the Diagnostics industry that focuses on the production and sale of reagents used in diagnostic tests. Diagnostic reagents are substances used to detect the presence of a particular disease or condition. They are used in a variety of medical tests, such as blood tests, urine tests, and tissue tests. Diagnostic reagents are typically produced in a laboratory setting and are used to detect the presence of a particular disease or condition. Diagnostic reagents are used in a variety of medical tests, such as blood tests, urine tests, and tissue tests. They are used to detect the presence of a particular disease or condition, and can be used to diagnose a variety of illnesses and conditions. Diagnostic reagents are typically produced in a laboratory setting and are used to detect the presence of a particular disease or condition. The Diagnostic Reagent market is highly competitive, with a number of companies offering a wide range of products. Some of the major players in the market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.